New machine-learning approach promises to speed drug design
A new approach to machine learning outperformed current machine-learning methods in drug design, demonstrating its potential in speeding up the drug discovery process, according to research published online November 29 in the Proceedings of the National Academy of Sciences. Read More
Immunicum, PCI Biotech extend alliance on novel cancer vaccines
Immunicum and PCI Biotech will jointly research introducing tumor-independent immune targets into the tumor microenvironment with vaccination or adoptive immunotherapies as a possibility of overcoming current hurdles in cancer immunotherapy. Read More
Northwest Biotherapeutics receives $15M in financing
Northwest Biotherapeutics, a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, has secured $15 million in financing to accelerate its brain cancer program. Read More
BioTools Innovator opens 2022 applications
BioTools Innovator is now accepting applications from startups and emerging growth companies for its second annual accelerator program. The program aims to advance innovation in life science and improve human health by accelerating the growth of best-in-class startups that are developing and commercializing biotechnology products, platforms, and services. Read More
Sartorius grows operations in France
Sartorius is expanding its capacities for production, innovation, and storage in France by investing 100 million euros ($117 million) between 2021 and 2025. Read More
Bone Therapeutics, Link Health enter agreement for rights of ALLOB
Bone Therapeutics and Link Health Pharma have signed a nonbinding agreement for the global rights regarding the development, manufacturing, and commercialization of ALLOB, Bone Therapeutics' off-the-shelf, human, allogeneic bone cell therapy derived from bone marrow mesenchymal stromal cells. The two companies plan to sign a binding license agreement by the end of 2021. Read More
Ranok Therapeutics, Pfizer team up on targeted protein degradation
Ranok Therapeutics and Pfizer are teaming up to evaluate Ranok's chaperone-mediated protein degradation platform technology on an undisclosed cancer target. Read More
Istari moves quickly to validate its poliovirus vaccine-based cancer immunotherapy
It's been a busy year for Istari Oncology, which is developing its PVSRIPO viral immunotherapy based on the poliovirus vaccine. Istari's President and CEO Matt Stober and Chief Medical Officer Dr. Garrett Nichols recently spoke with ScienceBoard about the progress of PVSRIPO for the treatment of solid tumors. Read More
Codex DNA, TriLink Biotechnologies launch automated mRNA synthesis kits
Codex DNA has launched its BioXp mRNA synthesis kits with CleanCap Reagent, a proprietary mRNA-capping technology from TriLink Biotechnologies, which is part of Maravai Life Sciences. The automation kits allow users to generate large quantities of high-quality, capped mRNA to accelerate the discovery and development of mRNA vaccines and therapeutics. Read More
Parallel Fluidics secures $1.8M in funding round
Digital microfluidic devices manufacturer Parallel Fluidics has garnered $1.8 million in a new round of financing from a syndicate of investors, founders, and technologists. Read More
Cell Bio 2021
December 11-15
San Diego, California United States
Antibody Engineering and Therapeutics
December 13-17
San Diego, California United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter